Rahmenvertrag für Rituximab 10mg/ml Infusionskonzentrat
Originaltitel der Bekanntmachung
Malta – Antineoplastic agents – CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Opportunity Score
Warum diese Bewertung?
Chance
71 / 100
Komplexität
42 / 100
Risikofaktoren
The notice text describes the contract as a framework contract, while structured data marks isFrameworkAgreement as fal...
Important procurement documents were available via URL but their extracted text was not provided, so technical, contrac...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- Department of Contracts
- Land
- Malta
- CPV
- 33652100 - Antineoplastic agents
- Frist
- Aug 04, 2026
- Geschätzter Wert
- EUR 1.4M
Überblick
Moderate opportunityWichtige Fakten
- EUR 1.4M estimated value
- Supplies contract
- 1 lot
- Supply of rituximab 10mg/ml concentrate for solution for infusion.
- Medical/antineoplastic pharmaceutical supplies for performance in Malta.
Vollständige Zusammenfassung anzeigen
Open supply tender in Malta for a framework contract to supply rituximab 10mg/ml concentrate for solution for infusion (CPV 33652100). One lot is shown. Estimated value is EUR 1,363,820.60. Electronic submission is required. Procurement documents are available via the e-tenders portal, but only the TED XML notice text was analyzed, not the full procurement documents.
Risiken
The notice text describes the contract as a framework contract, while structured data marks isFrameworkAgreement as fal...
Important procurement documents were available via URL but their extracted text was not provided, so technical, contrac...
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Administrative
- Electronic submission is required.
- Submission deadline: 2026-08-04T07:30:00Z according to structured data; XML text shows EndTime 09:30:00+02:00 on the same date, which corresponds to the same moment in UTC.
- Language of notice/tender is English; XML notice also detects Maltese.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Floriana, MLT
Website
Auftraggeberprofil
Kennung
MT25645419
Tätigkeit
General public services
Lose (1)
LOT-0001
Rituximab supply framework contract
Supply of rituximab 10mg/ml concentrate for solution for infusion in Malta. The lot is described as a framework contract in the notice, but the structured data flags isFrameworkAgreement as false, so there is an internal inconsistency. Value and scope are given at lot level.
EUR 1.4M
Geschätzter Wert
Ort
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Originale TED-Beschreibung
CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Vergabedetails
- Veröffentlichungsdatum
- 30 Jun 2026
- Sprachen
- English
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 452456-2026
Dokumente (2)
Ähnliche Ausschreibungen
Poland – Pharmaceutical products – produkty lecznicze w 309 pakietach dla potrzeb Apteki Szpitalnej Wojewódzkiego Szpitala Zespolonego w Elblągu
Poland – Pharmaceutical products – DOSTAWA LEKÓW I WYROBÓW MEDYCZNYCH
Poland – Pharmaceutical products – Dostawa produktów leczniczych - część nr 2
Poland – Pharmaceutical products – Dostawa leków stosowanych w programach lekowych
Poland – Pharmaceutical products – „Dostawa produktów leczniczych, środków specjalnego przeznaczenia żywieniowego, wyrobów medycznych, glukometrów, płynów kontrolnych oraz pasków do glukometrów do Apteki SP ZOZ Szpitala Wielospecjalistycznego w Jaworznie”
Lithuania – Antineoplastic agents – Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab ir (ar) Panitumumab)
Opportunity Score
Warum diese Bewertung?
Chance
71 / 100
Komplexität
42 / 100
Risikofaktoren
The notice text describes the contract as a framework contract, while structured data marks isFrameworkAgreement as fal...
Important procurement documents were available via URL but their extracted text was not provided, so technical, contrac...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications